Aim Stock Analysis Aim Immunotech Inc. Biotech Gains 8.18 Daily At 0.59 Price Level 20260403 FRPT Q1 2026 Earnings Steep Earnings Miss Highlights Cost Pressures at Freshpet MSDL Q1 2026 Earnings Narrow Earnings Beat as Stock Slips LTH Q1 2026 Earnings Strong EPS Beat Fails to Lift Shares GT Biopharma Q1 2026 Earnings WiderthanExpected Loss Amid Continued Development SXTP Q1 2026 Earnings Significant EPS Miss as Company Continues PreRevenue Phase First Mid Bancshares FMBH Q1 2026 Earnings EPS Surpasses Expectations by 531 Amid Steady Performance